Frankfurt - Delayed Quote EUR

Genflow Biosciences plc (WQ5.F)

0.0075

-0.0030

(-28.57%)

As of 9:59:01 AM GMT+2. Market Open.

Genflow Biosciences PLC Announces Final Results

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ...

ACCESS Newswire 4 days ago

GENFF
Genflow Biosciences PLC Announces Launch of AI-Powered Partnership

Genflow Biosciences Signs MSA with Heureka Labs, Launching AI-Powered Partnership in Gene Therapy Research LONDON, UNITED KINGDOM / ACCESS Newswire / April 14, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the ...

ACCESS Newswire 21 days ago

GENFF
Genflow Biosciences PLC Launches New Development Program

Genflow Biosciences Launches New Ophthalmology Development Program Signs MTA with Leading Ophthalmology Company LONDON, UK / ACCESS Newswire / April 10, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only ...

ACCESS Newswire 25 days ago

GENFF
Genflow Biosciences PLC Announces Holding in Company

LONDON, UNITED KINGDOM / ACCESS Newswire / March 28, 2025 /1. Issuer Details ISIN GB00BP2C3V08 Issuer Name GENFLOW BIOSCIENCES PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject ...

ACCESS Newswire last month

GENFF
Genflow Biosciences PLC Announces Director Dealings

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ...

ACCESS Newswire last month

GENFF
Genflow Biosciences PLC Announces Institutional Investment

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ...

ACCESS Newswire last month

GENFF
Genflow Biosciences PLC Announces Advancements in SIRT6 Variant Patent Application

LONDON, UK / ACCESS Newswire / February 20, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of ...

ACCESS Newswire 2 months ago

GENFF
Genflow Biosciences PLC Announces Holding(s) in Company - 2

1. Issuer Details ISIN GB00BP2C3V08 Issuer Name GENFLOW BIOSCIENCES PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Jonathan Mark Swann ...

ACCESS Newswire 3 months ago

GENFF
Genflow Biosciences PLC Announces Holding(s) in Company - 1

1. Issuer Details ISIN GB00BP2C3V08 Issuer Name GENFLOW BIOSCIENCES PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of financial instruments 3. Details of person subject to the notification obligation Name Premier ...

ACCESS Newswire 3 months ago

GENFF
Genflow Biosciences PLC Announces 2024 Highlights

2024 has been an incredible year for Genflow as we advance our mission to develop novel therapeutics that promote a longer, healthier life. Our focus on the SIRT6 gene and its potential to slow aging and delay age-related diseases has seen significant ...

ACCESS Newswire 3 months ago

GENFF
Genflow Secures Non-Dilutive Financial Support

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ...

ACCESS Newswire 6 months ago

GENFF
OTC Markets Hosts Virtual Investor Presentation with Eric Leire, Founder & CEO of Genflow Biosciences, and Brad Sorensen, Senior Analyst at Zacks SCR

OTCQB: GENFF | LSE: GENF OTC Markets: Hello and welcome to Virtual Investor Conferences. On behalf of OTC Markets and our co-host, Zacks Small-Cap Research, we're very pleased you have joined us for our next live presentation from Genflow Biosciences. Your session will be moderated by Brad Sorensen, Senior Equity Research Analyst with Zacks Small-Cap Research. Please note, you can submit

Zacks Small Cap Research 6 months ago

GENFF
Genflow Biosciences PLC Announces Half-year Report

LONDON, UNITED KINGDOM / ACCESSWIRE / September 30, 2024 / Genflow (LSE:GENF) is pleased to announce its half year results for the six-month period ended 30 June 2024. Chairman's Statement It is with pleasure that I take this opportunity to update ...

ACCESS Newswire 7 months ago

GENFF
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Virtual Investor Forum held September 19th are now available for online viewing. This event was co-sponsored by Zacks Small-Cap Research. REGISTER NOW AT: https://bit.ly/3TuSFdy The company presentations will be available 24/

GlobeNewswire 7 months ago

BVAXF

EVAX

PLX
Life Sciences Virtual Investor Forum Agenda Announced for September 19th

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Life Sciences Virtual Investor Forum to be held September 19th. This event is co-sponsored by Zacks Small-Cap Research Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER NOW AT: https://bit.ly/3XnsBlt It

GlobeNewswire 7 months ago

BVAXF

AEMD

PLX
Genflow Biosciences Plc to Present at the Life Sciences Investor Forum September 19th

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.comLONDON, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Genflow Biosciences Plc (LSE:GENF OTCQB:GENFF), based in the UK, focused on pioneering gene therapies to decelerate the aging process, today announced that Dr Eric Leire, Chief Executive Officer, will present live at the Life Sciences Investor Forum, hosted by VirtualInvestorConferences.com, on September 19th 2024.

GlobeNewswire 7 months ago

GENFF
Genflow Biosciences Plc Announces Result of AGM

LONDON, UNITED KINGDOM / ACCESSWIRE / June 27, 2024 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention ...

ACCESS Newswire 10 months ago

GENFF
Genflow Biosciences PLC Announces Strengthening of Pre-Clinical Efforts

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ...

ACCESS Newswire 10 months ago

GENFF
Genflow Biosciences PLC Announces Receipt of Grant Funding

Receipt of Grant Funding LONDON, UK / ACCESSWIRE / June 12, 2024 / THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT ...

ACCESS Newswire 10 months ago

GENFF
Genflow Biosciences PLC Announces Notice of AGM

Genflow Biosciences Plc Notice of Annual General Meeting LONDON, UNITED KINGDOM / ACCESSWIRE / June 3, 2024 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, focused ...

ACCESS Newswire 10 months ago

GENFF

Performance Overview

Return	WQ5.F	FTSE 100 (^FTSE)
YTD	-61.54%	+5.18%
1-Year	-67.39%	+4.66%
3-Year	-91.94%	+14.57%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Genflow Biosciences plc (WQ5.F)

Genflow Biosciences PLC Announces Final Results

Genflow Biosciences PLC Announces Launch of AI-Powered Partnership

Genflow Biosciences PLC Launches New Development Program

Genflow Biosciences PLC Announces Holding in Company

Genflow Biosciences PLC Announces Director Dealings

Genflow Biosciences PLC Announces Institutional Investment

Genflow Biosciences PLC Announces Advancements in SIRT6 Variant Patent Application

Genflow Biosciences PLC Announces Holding(s) in Company - 2

Genflow Biosciences PLC Announces Holding(s) in Company - 1

Genflow Biosciences PLC Announces 2024 Highlights

Genflow Secures Non-Dilutive Financial Support

OTC Markets Hosts Virtual Investor Presentation with Eric Leire, Founder & CEO of Genflow Biosciences, and Brad Sorensen, Senior Analyst at Zacks SCR

Genflow Biosciences PLC Announces Half-year Report

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

Life Sciences Virtual Investor Forum Agenda Announced for September 19th

Genflow Biosciences Plc to Present at the Life Sciences Investor Forum September 19th

Genflow Biosciences Plc Announces Result of AGM

Genflow Biosciences PLC Announces Strengthening of Pre-Clinical Efforts

Genflow Biosciences PLC Announces Receipt of Grant Funding

Genflow Biosciences PLC Announces Notice of AGM

Performance Overview